Dolphin Medical — 360° view

Dolphin Medical, a company in the Healthcare Service Provider industry, reported revenue of ₹0.41 crore and net profit of ₹0.02 crore for the September 2026 quarter.

Dolphin Medical (BSE: DOLPHMED) closed at ₹7.83 on 16 Nov 2026, up 278.3% over the past year. Its market capitalisation is ₹12 crore and it trades at 197.0 times earnings.

Share price
₹7.83 (16 Nov 2026)
Market cap
₹12 Cr (16 Nov 2026)
P/E
196.98 (16 Nov 2026)
Revenue
₹0 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
0.64% (FY26)
ROE
0.40% (FY26)
Book value
₹6.69 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹9.57 / ₹2.03 (16 Nov 2026)
1-year return
278.3% (to 16 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: DOLPHMED

Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and other allied services.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.